Health
The Benefit of Resuming Use of the J&J COVID-19 Vaccine – University of Utah Health Care
The CDC and the FDA recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. After carefully reviewing the data,…
May 07, 2021 10:00 AM
Author:
Kylene Metzger
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. The pause followed reports of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS), or vaccine-induced thrombotic thrombocytopenia (VITT), which causes blood clots with low platelets among a small number of people, mostly women younger…
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General19 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News18 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business22 hours agoThese ASX 200 shares could rise 55% to 65%